Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wechsler

Showing results (91-100 of 213) with videos related to

Pageof 22
Sort By:
The British Journal of Ophthalmology|March 24, 2000
Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarringH Ghiasi, S Cai, G C Perng, et al.
Antiviral Research|April 25, 2000
The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infectionH Ghiasi, S Cai, G C Perng, et al.
Journal of Virology|March 1, 1996
A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1G C Perng, S M Slanina, H Ghiasi, et al.
Journal of Virology|February 1, 1996
The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcriptG C Perng, H Ghiasi, S M Slanina, et al.
The Journal of General Virology|April 12, 2001
The effect of latency-associated transcript on the herpes simplex virus type 1 latency-reactivation phenotype is mouse strain-dependentGuey-Chuen Perng, Susan M Slanina, Homayon Ghiasi, et al.
Journal of Virology|May 1, 1996
High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivationG C Perng, H Ghiasi, S M Slanina, et al.
Neurology|October 13, 2004
Changes in cognitive function after neuronal cell transplantation for basal ganglia strokeC S Stilley, C M Ryan, D Kondziolka, et al.
Investigative Ophthalmology & Visual Science|June 10, 1998
A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal diseaseA B Nesburn, R L Burke, H Ghiasi, et al.
Cornea|April 15, 2005
A viral model for corneal scarring and neovascularization following ocular infection of rabbits with a herpes simplex virus type 1 (HSV-1) mutantCharles A Barsam, David J Brick, Clinton Jones, et al.
Virology|January 6, 1999
Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbitsA B Nesburn, R L Burke, H Ghiasi, et al.
Pageof 22

Showing results (91-100 of 213) with videos related to

Sort By:
Pageof 22
The British Journal of Ophthalmology|March 24, 2000
Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarringH Ghiasi, S Cai, G C Perng, et al.
Antiviral Research|April 25, 2000
The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infectionH Ghiasi, S Cai, G C Perng, et al.
Journal of Virology|March 1, 1996
A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1G C Perng, S M Slanina, H Ghiasi, et al.
Journal of Virology|February 1, 1996
The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcriptG C Perng, H Ghiasi, S M Slanina, et al.
The Journal of General Virology|April 12, 2001
The effect of latency-associated transcript on the herpes simplex virus type 1 latency-reactivation phenotype is mouse strain-dependentGuey-Chuen Perng, Susan M Slanina, Homayon Ghiasi, et al.
Journal of Virology|May 1, 1996
High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivationG C Perng, H Ghiasi, S M Slanina, et al.
Neurology|October 13, 2004
Changes in cognitive function after neuronal cell transplantation for basal ganglia strokeC S Stilley, C M Ryan, D Kondziolka, et al.
Investigative Ophthalmology & Visual Science|June 10, 1998
A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal diseaseA B Nesburn, R L Burke, H Ghiasi, et al.
Cornea|April 15, 2005
A viral model for corneal scarring and neovascularization following ocular infection of rabbits with a herpes simplex virus type 1 (HSV-1) mutantCharles A Barsam, David J Brick, Clinton Jones, et al.
Virology|January 6, 1999
Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbitsA B Nesburn, R L Burke, H Ghiasi, et al.
Pageof 22